Herantis Pharma to participate in Bio€quity Europe 2023 in Dublin May 2023
Herantis Pharma Plc, Press Release, 2 May 2023 at 11:45 A.M. EEST Herantis Pharma Plc (“Herantis”), a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease, today announced that Herantis Pharma has been selected as presenting company with live presentation during the 23rd Bio€quity Europe Conference, in May 14-16, 2023 in Dublin. CEO, Antti Vuolanto will give a company presentation: May 16[th] at 11:39 AM EEST / 10:39 AM CET / 09:39 AM IST Location: Liffey Meeting Room 3, Convention Centre Dublin If you want 1x1 meetings with